Original Article
Lysophosphatidylcholine-induced modulation of Ca2+-activated K+channels contributes to ROS-dependent proliferation of cultured human endothelial cells

https://doi.org/10.1016/j.yjmcc.2004.03.001Get rights and content

Abstract

Proliferation of endothelial cells plays a crucial role in the process of atherosclerotic plaque destabilization. The major component of oxidized low-density lipoprotein lysophosphatidylcholine (LPC) has been shown to promote endothelial proliferation by increasing the production of reactive oxygen species (ROS). Since K+ channels are known to control the cell cycle, we investigated the role of Ca2+-activated K+ channels (BKCa) in the regulation of LPC-induced endothelial proliferation and ROS generation. A significant increase of cell growth induced by LPC (20 μmol/l; cell counts (CCs): +87%, thymidin incorporation: +89%; n = 12, P < 0.01) was observed, which was inhibited by the BKCa inhibitor iberiotoxin (IBX; 100 nmol/l), by the NAD(P)H-oxidase inhibitor diphenyleneiodonium (5 μmol/l) and by transfection with antisense (AS) oligonucleotides against NAD(P)H oxidase, whereas NG-monomethyl-l-arginine (l-NMMA) further increased LPC-induced cell growth. Using the patch-clamp technique a significant increase of BKCa open-state probability (control: 0.004 ± 0.002; LPC: 0.104 ± 0.035; n = 21, P < 0.05) by LPC was observed. Using dichlorofluorescein fluorescence microscopy a significant increase of ROS induced by LPC was reported, that was blocked by IBX and Ca2+ antagonists. Intracellular Ca2+ measurements revealed a capacitative Ca2+ influx caused by LPC. Bioactivity of nitric oxide (NO) was measured using a [3H]-cGMP radioimmunoassay. LPC significantly decreased acetylcholine-induced NO synthesis. LPC significantly increased cGMP levels in endothelial cells transfected with AS, which was blocked by IBX. In conclusion, our results demonstrate that LPC activates BKCa thereby increasing ROS production which induces endothelial proliferation. In addition LPC-induced BKCa-activation contributes to increased cGMP levels, if ROS production is prevented by AS.

Introduction

Atherosclerosis can be seen as a chronic inflammatory disease, in which increased cellular turnover on the one hand and apoptotic/necrotic cell death on the other hand takes place within the vascular wall [1], [2], [3]. Besides hypertension, diabetes mellitus, and nicotine abuse, low-density lipoproteins (LDLs) play a major role in the pathogenesis of atherosclerosis. The oxidative modification of LDL, during which lysophosphatidylcholine (LPC) accumulates within the LDL particle, seems to be a key event in this process [4].

It has been shown in an animal-atherosclerosis model, that endothelium-dependent vasorelaxation is impaired, if endothelium-derived nitric oxide (NO) or its biological activity is decreased [5], [6]. The vascular production of reactive oxygen species (ROS) is dramatically increased in atherosclerotic arteries, which is of great importance since superoxide is known to inactivate NO in a chemical reaction during which peroxynitrite is formed [7]. Therefore, oxidative inactivation of NO is regarded as an important cause of its decreased biological activity [8].

Another well recognized feature in atherosclerotic lesions is intimal angiogenesis. Angiogenesis is implicated in the development of atherosclerosis and associated clinical syndromes in the coronary circulation [9], [10]. It has been suggested that the vascular wall of these new blood vessels is weak and therefore subject to rupture. Intramural hemorrhage from these microvessels may precipitate the clinical complications of atherosclerosis with sudden expansion and rupture of the plaque in association with arterial dissection, ulceration, or thrombosis [11].

It has previously been shown that oxidized LDL (oxLDL) and LPC induce endothelial proliferation by increasing the superoxide production of the NAD(P)H oxidase [12]. Recently, we have reported that modulation of Ca2+-activated K+ channels (BKCa) is involved in oxLDL-induced endothelial proliferation and NO production [13]. BKCa have been shown to regulate the membrane potential and thereby influence intracellular Ca2+ levels. Endothelial cell functions are strongly influenced by changes of the intracellular Ca2+ homeostasis [14]. In endothelial cells, which do not express voltage-gated Ca2+ channels [15] changes of intracellular Ca2+ concentrations ([Ca2+]i) are mainly due to Ca2+ release from internal stores or through transmembrane Ca2+ influx, which depends on membrane hyperpolarization [14].

In this study, we investigated whether LPC modulates endothelial BKCa thereby influencing the intracellular Ca2+ homeostasis, and whether this ion channel is involved in the LPC-induced changes of ROS generation, cell proliferation, and NO bioactivity.

Section snippets

Isolation and culture of HUVEC

Endothelial cells were isolated from human umbilical cord veins (HUVEC) by collagenase digestion procedure as described previously [13]. The endothelial cell basal medium (EBM) was enriched with 10% fetal calf serum (FCS) and the following substances: 0.4% ECGS/H, epidermal growth factor 0.1 ng/ml, hydrocortisone 1 μg/ml, basic fibroblast factor 1 ng/ml, and gentamicin 50 μg/ml. The culture medium was changed every 48 h. All experiments were carried out using endothelial cells from subcultures

LPC activates BKCa in human endothelial cells

BKCa has been identified in HUVEC extensively in our laboratory previously [13], [17]. It has been shown to be voltage dependent with a single-channel slope conductance of 170.3 ± 2.1 pS (n = 7) being well within the range of BKCa’s characteristic conductance of 150–250 pS. Furthermore, the highly specific BKCa blocker IBX (100 nmol/l) was seen to cause a complete block of unitary outward currents observed in cultured human endothelial cells, establishing that these unitary outward currents are

Discussion

The aim of our study was to investigate the underlying mechanisms that are involved in LPC-induced ROS formation and its contribution to endothelial proliferation. During the oxidative modification of LDL, LPC accumulates in the oxLDL particle [19].

Data, recently published by our group, demonstrates that oxLDL modulates BKCa in human endothelial cells [13]. Therefore, we examined the effect of LPC on BKCa single-channel activity in cell-attached patches, using the patch-clamp technique. Our

References (38)

  • M.M. Kockx et al.

    Apoptosis and related proteins in different stages of human atherosclerotic plaques

    Circulation

    (1998)
  • R. Ross

    Mechanisms of disease: atherosclerosis—an inflammatory disease

    New Engl J Med

    (1999)
  • D. Steinberg et al.

    Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity

    New Engl J Med

    (1989)
  • J.P. Cooke et al.

    Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

    Circulation

    (1991)
  • L.J. Ignarro

    Biosynthesis and metabolism of endothelium-derived nitric oxide

    Annu Rev Pharmacol Toxicol

    (1990)
  • E.R. O’Brien et al.

    Angiogenesis in human coronary atherosclerotic plaques

    Am J Pathol

    (1994)
  • A.C. Barger et al.

    Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis

    New Engl J Med

    (1984)
  • A. Heinloth et al.

    Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells

    J Am Soc Nephrol

    (2000)
  • C.R.W. Kuhlmann et al.

    Modulation of endothelial Ca(2+)-activated K(+) channels by oxidized LDL and its contribution to endothelial proliferation

    Cardiovasc Res

    (2003)
  • Cited by (0)

    View full text